Dr. Quoc B Nguyen, M.D., M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 E Lambert Rd, Brea, CA 92821 Phone: 714-672-5100 Fax: 714-672-5029 |
Paulynne P Liang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 W Imperial Hwy Ste 110, Brea, CA 92821 Phone: 714-449-6900 |
Dr. Adrian A. Bose, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 N. Brea Blvd., Brea, CA 92821 Phone: 714-529-6842 Fax: 714-256-1041 |
Dr. Franklin L Dawes, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 407 W Imperial Hwy, H-171, Brea, CA 92821 Phone: 562-365-3540 Fax: 562-365-3532 |
Dr. Nadia Saber Tadros, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1900 E Lambert Rd, Brea, CA 92821 Phone: 714-672-5210 |
Siera Panhwar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 W Imperial Hwy # H171, Brea, CA 92821 Phone: 562-365-3540 Fax: 562-365-3532 |
Dr. Edward R Hutchison, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2874 E Imperial Hwy, Brea, CA 92821 Phone: 714-996-2390 Fax: 714-996-3804 |
Pearl P D'sa, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 W Imperial Hwy # H-171, Brea, CA 92821 Phone: 562-365-3540 Fax: 562-365-3532 |
News Archive
As a level-one trauma and accredited stroke center, time is critical at Summa Health System's Akron City Hospital, located in Akron, Ohio. To provide the highest level of patient care, the hospital installed an Aquilion ONE CT scanner and Infinix-i bi-plane cardiovascular X-ray from Toshiba America Medical Systems, Inc.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Dilon Technologies, Inc., the leader in molecular breast imaging, today announced the release of the newest Dilon 6800 Software update including enhancements for both breast and general nuclear medicine applications image processing. The new software functionalities complement the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator for general nuclear medicine applications, both released earlier this year as purchase options for the Dilon 6800 gamma camera.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that the underwriters of its recently completed initial public offering of common stock have exercised their option to purchase an additional 968,539 shares of common stock to cover over-allotments.
In an update of the project portfolio, Karo Bio announced, among other things, that the company, in accordance with earlier communicated plans, has submitted an IND application for eprotirome to the American Food and Drug Administration (FDA); that a candidate drug has been nominated within the ER-beta program; and that the company has decided not to initiate further in-house development of KB3305 for the treatment of type 2 diabetes.
› Verified 1 days ago